Detalhe da pesquisa
1.
[Assessment of compliance and patient pathway among multiple sclerosis patients on disease modifying treatment]. / Compliance- és betegútvizsgálat betegségmódosító kezelés alatt álló sclerosis multiplexes betegeknél.
Ideggyogy Sz
; 76(9-10): 309-317, 2023 Sep 30.
Artigo
em Húngaro
| MEDLINE | ID: mdl-37782063
2.
New insights into the burden and costs of multiple sclerosis in Europe: Results for Hungary.
Mult Scler
; 23(2_suppl): 91-103, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28643591
3.
Treatment of relapsing multiple sclerosis in Hungary - consensus recommendation from the Hungarian neuroimmunology society.
Orphanet J Rare Dis
; 18(1): 183, 2023 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37420270
4.
Do Hungarian multiple sclerosis care units fulfil international criteria?
PLoS One
; 17(3): e0264328, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239686
5.
Contributing factors to health-related quality of life in multiple sclerosis.
Brain Behav
; 9(12): e01466, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31709732
6.
Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
Mult Scler Relat Disord
; 17: 57-62, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29055476
7.
Effects of interrupted immunomodulant therapy on the neurological state of multiple sclerosis patients.
J Neurol Sci
; 260(1-2): 296-7, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17475280
8.
APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis.
Swiss Med Wkly
; 140: w13119, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21110240
9.
Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis.
J Neuroimmunol
; 208(1-2): 115-8, 2009 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19201038